Divine Skin Starts Lucrative Partnership With NutraOrigin, Expanding Into Nutritional Supplements
MIAMI BEACH, Fla., July 12, 2011 /PRNewswire/ -- Expanding into the lucrative market for nutritional supplements, biotech developer Divine Skin Inc. (DSKX) signed an exclusive deal with NutraOrigin, with 63 comprehensive formulas designed to be incorporated easily into any health regimen. With this agreement Divine Skin acquires exclusive access to NutraOrigin technologies and will receive 30% of all revenue generated with NutraOrigin products globally.
NutraOrigin's Omega line is the first brand of high-potency omega-3 fatty acids proven effective in large-scale clinical trials. In a recent double-blind study conducted for a US government agency, volunteers taking the NutraOrigin product improved reaction time and accuracy and reduced drowsiness and anxiety.
CEO Daniel Khesin said, "NutraOrigin fits perfectly into Divine Skin's model of performance-driven innovation and cutting-edge technology. In particular we are very excited about the significant advances in the fish oil category."
In the United States, manufacturers' revenues from vitamins and nutrients for human use total $9 billion per year, and fish oils alone top $280 million, according to an August 2010 report by the US Census Bureau.
Khesin also announced that Divine Skin has been actively working with NutraOrigin and has signed a deal with Whole Foods Market to launch NutraOrigin at retail. Last month, he announced a new pharmaceutical drug designed to compete with Tylenol, Advil, and aspirin.
About NutraOrigin
The cutting-edge nutritional supplements from NutraOrigin, manufactured in the United States, are the result of exhaustive research to maximize the role of nutritional compounds in humans.
The Omega line, demonstrated in trials to boost mental function, now comprises 28 SKUs. They include softgels with fish oil, krill oil, and other sources of omega-3 fatty acids, plus shakes in pleasant fruit flavors, gummies for kids, and oils for pets.
The Clinical line has 24 SKUs. Blends target users concerned about aging, fatigue, depression, insomnia, headaches, glucose, cholesterol, obesity, osteoporosis, oxidation, indigestion, inflammation, immunity, mobility, menopause, memory loss, sight loss, hair thinning, premenstrual syndrome, and benign prostatic hyperplasia.
The Vitamin line, with 11 SKUs, includes tablets, softgels, and gummies targeted to men, women, kids, and seniors. www.NutraOrigin.com
About Divine Skin
Divine Skin Inc. is a biotechnology company engaged in the development of topical therapies and over-the-counter drugs that can be brought to market quickly, without lengthy regulatory requirements. In its consumer division, the company develops, markets, and distributes personal-care products through cosmetics wholesalers, online retailers, specialty outlets, spas, salons, and medical offices in more than 20 countries. Its brands include DS Laboratories, Sigma Skin, Polaris Research Laboratories, and The Pure Guild.
DS Laboratories, the flagship brand, offers high-performance topical solutions for men and women to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, maintain feminine hygiene, and reduce the appearance of cellulite, wrinkles, and double chins (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers such as Bergdorf Goodman and Neiman Marcus in the United States, Saks Fifth Avenue in Mexico, and Harvey Nichols in the United Kingdom. Products are designed to reverse hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild, the newest brand, offers purity with performance. The botanical compounds proven most effective in rigorous clinical trials are extracted mechanically, using no industrial solvents or damaging heat. The uncompromised treatments sell through ultra-premium food retailers (www.thepureguild.com).
Divine Skin's management believes the company has established itself as a leader in topical therapies, especially hair growth, through aggressive pursuit of innovation and technology. Products employ comprehensive formulas with multiple methods of action against common skin conditions. Many utilize proprietary encapsulation techniques for improved bioavailability.
Forward-Looking Statements:
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
SOURCE Divine Skin Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article